Pacifico, Corazon .

HRN: 26-68-44  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/26/2025
03/04/2025
IV
475 Mg
Q 48 Hrs
Prophylaxis
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: